Lipoglycopeptides

DBCAT004291Pharmacologic class

Glycopeptides that have an additional lipophilic side chains. Several semisynthetic lipoglycopeptide antibiotics are derived from naturally occurring lipoglycopeptide and glycopeptide antibiotics. A DrugBank category of 2 drugs. 2 of them are approved.

Drugs: Dalbavancin
Teicoplanin

What you can answer from here — as of September 06, 2018

2DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

132Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Lipoglycopeptides share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account